Variant report
Variant | nsv3867 |
---|---|
Chromosome Location | chr3:70480358-70525397 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:70475833..70478455-chr3:70482226..70483740,2 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MITF-9 | chr3:70488089-70488284 | NONHSAT090380 |
2 | lnc-MITF-9 | chr3:70484318-70484415 | NONHSAT090380 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549766153 | chr3:70483611-70483612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148038180 | chr3:70483624-70483625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531888654 | chr3:70483628-70483629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs548509777 | chr3:70483643-70483644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568409539 | chr3:70483652-70483653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs189491424 | chr3:70483692-70483693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs180737491 | chr3:70483693-70483694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs111582905 | chr3:70483696-70483697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs539519390 | chr3:70483709-70483710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528694256 | chr3:70483721-70483722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs58633750 | chr3:70483722-70483723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551073067 | chr3:70483728-70483729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs397799247 | chr3:70483730-70483731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552022387 | chr3:70483763-70483764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs571824395 | chr3:70483796-70483797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs150167484 | chr3:70483835-70483836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112607441 | chr3:70483837-70483838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572350553 | chr3:70483842-70483843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs374579880 | chr3:70483904-70483905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376231735 | chr3:70483938-70483939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs55891967 | chr3:70483949-70483950 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs536299730 | chr3:70483950-70483951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564093969 | chr3:70483965-70483966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs13434066 | chr3:70483966-70483967 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs543106612 | chr3:70483970-70483971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs55904862 | chr3:70483988-70483989 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs534540321 | chr3:70483997-70483998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs528899493 | chr3:70484010-70484011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs187506561 | chr3:70484018-70484019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192049990 | chr3:70484025-70484026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs577990527 | chr3:70484030-70484031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs527942649 | chr3:70484050-70484051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547990760 | chr3:70484110-70484111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs570908918 | chr3:70484118-70484119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539931639 | chr3:70484138-70484139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183205600 | chr3:70484151-70484152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570132348 | chr3:70484158-70484159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs563225687 | chr3:70484175-70484176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs199902681 | chr3:70484195-70484196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs149488809 | chr3:70484201-70484202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186048775 | chr3:70484214-70484215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190319669 | chr3:70484270-70484271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534889639 | chr3:70484297-70484298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs182562210 | chr3:70484307-70484308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558921319 | chr3:70484308-70484309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs2080640 | chr3:70484317-70484318 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs543598079 | chr3:70484328-70484329 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs148771944 | chr3:70484332-70484333 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs573384378 | chr3:70484333-70484334 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs142456728 | chr3:70484339-70484340 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Prostate cancer | 17217626 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Mental retardation | 20848658 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Mental retardation | 17847001 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:70483600-70484600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr3:70483600-70485000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr3:70484200-70485000 | Enhancers | H9 Cell Line | embryonic stem cell |
4 | chr3:70484200-70485000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr3:70489200-70489600 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
6 | chr3:70508200-70508400 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr3:70519800-70520600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr3:70520000-70521800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
9 | chr3:70520200-70521400 | Enhancers | HSMMtube | muscle |
10 | chr3:70520400-70521200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr3:70520600-70521200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr3:70521200-70521600 | Enhancers | Aorta | Aorta |
13 | chr3:70521200-70524600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
14 | chr3:70524200-70524800 | Enhancers | H9 Cell Line | embryonic stem cell |
15 | chr3:70524200-70525000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
16 | chr3:70524200-70525600 | Enhancers | H1 Cell Line | embryonic stem cell |
17 | chr3:70524200-70526400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
18 | chr3:70524400-70524800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
19 | chr3:70524400-70525600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
20 | chr3:70524400-70526400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
21 | chr3:70524600-70526000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
22 | chr3:70524800-70526000 | Weak transcription | H9 Cell Line | embryonic stem cell |
23 | chr3:70524800-70526200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
24 | chr3:70525000-70525600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |